88 results on '"dAmico, A"'
Search Results
2. Increased COL18a1/Endostatin Expression Correlates With Right Ventricular Fibrosis and Remodeling in the Sugen-hypoxic Rat Model of Pulmonary Hypertension
3. Regulatory T Cell-dependent Resolution of Pneumonia Requires DHX58-DEC2-GATA3
4. XOR Activity in Scleroderma Associated-PAH
5. Distinct Alveolar and Bone-Marrow Derived Macrophages Signatures After Bacterial Challenge
6. Right Ventricular Pulmonary Arterial Coupling Measured by Multi-beat Pressure Volume Loops Predicts Survival in Pulmonary Hypertension
7. MOBILIZAÇÃO PRECOCE EM INDIVIDUOS DE UNIDADE DE TERAPIA INTENSIVA: DESVENDANDO SEUS EFEITOS NOS EXAMES CLÍNICOS E NA RECUPERAÇÃO FUNCIONAL - UMA REVISÃO DE LITERATURA
8. The Neglected Dropout: General Track Students.
9. MicroRNA Regulation of the 3' Untranslated Region of COL18a1 in Pulmonary Arterial Hypertension
10. MiRNA-133-a as a Mediator of Endostatin-dependent Gene Expression in Pulmonary Arterial Hypertension
11. Phagocytic Role of DHX58 During the Resolution of Pneumonia-ARDS in Mice
12. Characterizing Endostatin-induced Changes in Endothelial Gene Expression: The Important Role of MicroRNA
13. miR-637/COL18a1 Expression in the Sugen-hypoxic Rat Model of Pulmonary Hypertension
14. Opal Reactor Training Simulator
15. Improved Survival for Systemic Sclerosis Associated Pulmonary Arterial Hypertension in the Last Decade
16. Cardiac Index: A Misleading Parameter in Risk Assessment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
17. Targets of miR-155 in Human Lung Microvascular Endothelial Cells: Implications for PAH
18. Resolution of Pneumonia/ARDS by DHX58 in Mice and Humans
19. Circulating Amino Acid Profiles in Pulmonary Arterial Hypertension at Rest and with Peak Exercise
20. Causes and Outcomes of Intensive Care Unit Hospitalizations in Patients with Pulmonary Arterial Hypertension
21. Hemodynamics and Survival in Systemic Sclerosis-Associated Pulmonary Hypertension
22. Peer Helping Relationships: An Ecological Study of an Elementary Classroom.
23. Staying in School: Social Learning Factors Which Lead to Retention.
24. Agglomerative clustering using hybrid features for image categorization.
25. Development of a Guideline-Based Approach to Perioperative Risk Assessment in Pulmonary Hypertension Patients Undergoing Non-Cardiac Surgery
26. Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension
27. microRNA-155-5p Is an Effector of Endostatin in Pulmonary Endothelial Cells
28. Abstract IA09: A phase II trial to promote recovery from COVID-19 with endocrine therapy
29. Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis
30. Effect of Endostatin on BMPR2 Expression in Human Lung Microvascular Endothelial Cells
31. Causes and Outcomes of Hospitalizations in Patients with Pulmonary Arterial Hypertension
32. Minimal Detectable Difference of Echocardiographic Variables in Systemic Sclerosis with and Without Pulmonary Arterial Hypertension
33. Utility of Echocardiography in Prognostic Stratification of Prevalent PAH Patients at Intermediate or High Mortality Risk
34. Differences and Prognostic Implications of Right Heart Echocardiographic Assessment Among Risk Categories in Prevalent PAH Patients
35. Serum endostatin as a genetically-influenced biomarker in PAH
36. Changes in Risk Category Among Patients with Systemic Sclerosis-Associated PAH Treated with Initial Combination Therapy in the ATPAHSS Trial
37. Genetic Variants in Xanthine Dehydrogenase in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
38. Circulating Serum ST2 as a Biomarker of Disease Severity and Survival in Pulmonary Arterial Hypertension
39. Subtypes and Outcomes of Sarcoidosis-Associated Pulmonary Hypertension
40. Hepatoma-Derived Growth Factor (HDGF) Is a Predictor of Disease Severity and Survival in Pulmonary Arterial Hypertension and Highly Associated with Portal Pulmonary Hypertension
41. Identification of Insulin-Like Growth Factor Binding Protein-2 (IGFBP2) as a Novel Biomarker for Pulmonary Arterial Hypertension Severity and Survival
42. Characterization of Chronic Obstructive Pulmonary Disease-Pulmonary Hypertension
43. Ventricular mass index predicts mortality in incident patients with PAH
44. ESC/ERS low-risk profile achievement accurately predicts mortality in scleroderma-associated PAH
45. FERRAMENTAS DE GESTÃO ESTRATÉGICA PARA OTIMIZAÇÃO DE DESEMPENHO
46. Supraventricular Arrhythmias in Pulmonary Arterial Hypertension
47. Right ventricular strain differences between idiopathic and systemic sclerosis Pulmonary Hypertension
48. Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial
49. Chalcogenide Glasses for Mid-IR Photonic Applications
50. Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’ implants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.